Zhao Yanyan, Wu Caixia, Li Wei, Chen Xueqi, Li Ziao, Liao Xuhe, Cui Yonggang, Zhao Guangyu, Liu Meng, Fu Zhanli
Department of Nuclear Medicine, Peking University First Hospital, Beijing, China.
Department of Nuclear Medicine, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):570-579. doi: 10.1007/s00259-020-04996-4. Epub 2020 Aug 19.
To explore the potential parameters from preoperative 2-[F]FDG PET/CT that might associate with the World Health Organization/the International Society of Urological Pathology (WHO/ISUP) grade in clear cell renal cell carcinoma (ccRCC).
One hundred twenty-five patients with newly diagnosed ccRCC who underwent 2-[F]FDG PET/CT prior to surgery or biopsy were retrospectively reviewed. The metabolic parameters and imaging features obtained from 2-[F]FDG PET/CT examinations were analyzed in combination with clinical characteristics. Univariate and multivariate logistic regression analyses were performed to identify the predictive factors of WHO/ISUP grade.
Metabolic parameters of primary tumor maximum standardized uptake value (SUVmax), tumor-to-liver SUV ratio (TLR), and tumor-to-kidney SUV ratio (TKR) were significantly different between any two of the four different WHO/ISUP grades, except those between the WHO/ISUP grade 3 and grade 4. The optimal cutoff values to predict high WHO/ISUP grade for SUVmax, TLR, and TKR were 4.15, 1.63, and 1.59, respectively. TLR (AUC: 0.841) was superior to TKR (AUC: 0.810) in distinguishing high and low WHO/ISUP grades (P = 0.0042). In univariate analysis, SUVmax, TLR, TKR, primary tumor size, tumor thrombus, distant metastases, and clinical symptoms could discriminate between the high and low WHO/ISUP grades (P < 0.05). In multivariate analysis, TLR (P < 0.001; OR: 1.732; 95%CI: 1.289-2.328) and tumor thrombus (P < 0.001; OR: 6.199; 95%CI: 2.499-15.375) were significant factors for differentiating WHO/ISUP grades.
Elevated TLR (> 1.63) and presence of tumor thrombus from preoperative 2-[F]FDG PET/CT can distinguish high WHO/ISUP grade ccRCC effectively. 2-[F]FDG PET/CT may be a feasible method for noninvasive assessment of WHO/ISUP grade.
探讨术前2-[F]FDG PET/CT的潜在参数,这些参数可能与透明细胞肾细胞癌(ccRCC)的世界卫生组织/国际泌尿病理学会(WHO/ISUP)分级相关。
回顾性分析125例新诊断的ccRCC患者,这些患者在手术或活检前接受了2-[F]FDG PET/CT检查。结合临床特征分析从2-[F]FDG PET/CT检查中获得的代谢参数和影像特征。进行单因素和多因素逻辑回归分析以确定WHO/ISUP分级的预测因素。
在四个不同的WHO/ISUP分级中的任意两个之间,原发肿瘤最大标准化摄取值(SUVmax)、肿瘤与肝脏SUV比值(TLR)和肿瘤与肾脏SUV比值(TKR)的代谢参数存在显著差异,但WHO/ISUP 3级和4级之间除外。预测高WHO/ISUP分级的SUVmax、TLR和TKR的最佳截断值分别为4.15、1.63和1.59。在区分高和低WHO/ISUP分级方面,TLR(AUC:0.841)优于TKR(AUC:0.810)(P = 0.0042)。在单因素分析中,SUVmax、TLR、TKR、原发肿瘤大小、肿瘤血栓、远处转移和临床症状可区分高和低WHO/ISUP分级(P < 0.05)。在多因素分析中,TLR(P < 0.001;OR:1.732;95%CI:1.289 - 2.328)和肿瘤血栓(P < 0.001;OR:6.199;95%CI:2.499 - 15.375)是区分WHO/ISUP分级的重要因素。
术前2-[F]FDG PET/CT中TLR升高(> 1.63)和存在肿瘤血栓可有效区分高WHO/ISUP分级的ccRCC。2-[F]FDG PET/CT可能是一种非侵入性评估WHO/ISUP分级的可行方法。